Clinical trial
An Exploratory Phase 2 Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Investigate the Safety, Tolerability, and Efficacy of TML-6 in Early Alzheimer's Disease
NCT07612150 is registered in ClinicalTrials.gov with Merry Life Biomedical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Phase 2 Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Investigate the Safety, Tolerability, and Efficacy of TML-6 in Early Alzheimer's Disease
- Lead sponsor
- Merry Life Biomedical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- July 31, 2028
- Enrollment
- 210 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.